Development of pathogenesis-based therapy for polyglutamine diseases

多聚谷氨酰胺疾病的基于发病机制的治疗方法的开发

基本信息

  • 批准号:
    17025020
  • 负责人:
  • 金额:
    $ 106.94万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
  • 财政年份:
    2005
  • 资助国家:
    日本
  • 起止时间:
    2005 至 2009
  • 项目状态:
    已结题

项目摘要

In this study, we demonstrated that the disruption of TGF-β signaling by the pathogenic androgen receptor (AR) is associated with polyglutamine-induced motor neuron damage in SBMA. Our in vivo analyses also showed that Hsp90 inhibitors facilitate proteasomal degradation of the pathogenic AR. These results indicate that pharmacological modification of UPS activity and cellular signals such as TGF-β appear to be promising therapeutic approaches for SBMA and other polyglutamine diseases.
在这项研究中,我们证明了致病性雄激素受体(AR)对TGF-β信号传导的破坏与SBMA中聚谷氨酰胺诱导的运动神经元损伤相关。我们的体内分析还表明,热休克蛋白90抑制剂促进蛋白酶体降解的致病性AR。这些结果表明,UPS活性和细胞信号(如TGF-β)的药理学修饰似乎是SBMA和其他多聚谷氨酰胺疾病的有希望的治疗方法。

项目成果

期刊论文数量(93)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
In vitro and in silico analysis reveals an efficient algorithm to predict the splicing consequences of mutations at the 5' splice sites.
  • DOI:
    10.1093/nar/gkm647
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    14.9
  • 作者:
    Sahashi K;Masuda A;Matsuura T;Shinmi J;Zhang Z;Takeshima Y;Matsuo M;Sobue G;Ohno K
  • 通讯作者:
    Ohno K
Clinical and electrophysiologic correlates of IVIg responsiveness in CIDP
  • DOI:
    10.1212/01.wnl.0000158680.89323.f8
  • 发表时间:
    2005-04-26
  • 期刊:
  • 影响因子:
    9.9
  • 作者:
    Iijima, M;Yamamoto, M;Sobue, G
  • 通讯作者:
    Sobue, G
CHIP overexpression reduces mutant androgen receptor protein and ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model
  • DOI:
    10.1523/jneurosci.1242-07.2007
  • 发表时间:
    2007-05-09
  • 期刊:
  • 影响因子:
    5.3
  • 作者:
    Adachi, Hiroaki;Waza, Masahiro;Sobue, Gen
  • 通讯作者:
    Sobue, Gen
Usefulness of combined fractional anisotropy and apparent diffusion coefficient values for detection of involvement in multiple system atrophy
Intravenous immunoglobulin therapy markedly ameliorates muscle weakness and severe pain in proximal diabetic neuropathy
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SOBUE Gen其他文献

SOBUE Gen的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SOBUE Gen', 18)}}的其他基金

Therapeutic strategy of neurodegenerative disease using microRNA
利用microRNA治疗神经退行性疾病的策略
  • 批准号:
    25670418
  • 财政年份:
    2013
  • 资助金额:
    $ 106.94万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Identification of therapeutic targets for ALS by screening for TDP-43 and FUS associated molecules
通过筛选 TDP-43 和 FUS 相关分子鉴定 ALS 治疗靶点
  • 批准号:
    23659452
  • 财政年份:
    2011
  • 资助金额:
    $ 106.94万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Development of Molecular Targeted Disease Modifying Therapy for Polyglutamine Diseases
多聚谷氨酰胺疾病分子靶向疾病修饰疗法的发展
  • 批准号:
    21229011
  • 财政年份:
    2009
  • 资助金额:
    $ 106.94万
  • 项目类别:
    Grant-in-Aid for Scientific Research (S)
Pathogenesis-based therapy development for polyglutamine diseases
多聚谷氨酰胺疾病的基于发病机制的治疗方法开发
  • 批准号:
    19209033
  • 财政年份:
    2007
  • 资助金额:
    $ 106.94万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Treatment of polyglutamine disease using small molecular compound
小分子化合物治疗多聚谷氨酰胺病
  • 批准号:
    17209032
  • 财政年份:
    2005
  • 资助金额:
    $ 106.94万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Development of Pathogenesis-based treatment for spinal and bulbar muscular atrophy
脊髓和延髓性肌萎缩症基于发病机制的治疗方法的开发
  • 批准号:
    15209031
  • 财政年份:
    2003
  • 资助金额:
    $ 106.94万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Elucidation of molecular mechanism of neuronal cell death in spinal and bulbar muscular atrophy
阐明脊髓和延髓肌萎缩症中神经元细胞死亡的分子机制
  • 批准号:
    12210010
  • 财政年份:
    2000
  • 资助金额:
    $ 106.94万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
Neurotrophin and their receptor mRNA expressions in neurodegenerative diseases.
神经营养蛋白及其受体 mRNA 在神经退行性疾病中的表达。
  • 批准号:
    06807059
  • 财政年份:
    1994
  • 资助金额:
    $ 106.94万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
GENE EXPRESSION AND REGULATION OF NEUROTROPHINS AND THEIR RECEPTORS IN PERIPHERAL NEUROPATHIES
周围神经病中神经营养因子及其受体的基因表达和调节
  • 批准号:
    02807085
  • 财政年份:
    1990
  • 资助金额:
    $ 106.94万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了